Michael John Isaacs
Known title: General Counsel & Company Sec.CIK: 0002127815
Associated companies
Transaction History
| PRTA | ▼ Sell | Open Market | 8,386 | $71K | 7/29/2026 | View on chart |
| PRTA | ▼ Sell | Tax Withholding | 4,694 | $40K | 7/28/2026 | View on chart |
| PRTA | ▼ Sell | Open Market | 8,386 | $71K | 7/29/2026 | View on chart |
| PRTA | ▼ Sell | Tax Withholding | 4,694 | $40K | 7/28/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Prothena included in Alzheimer's Day stock watchlist
Prothena was featured in a Yahoo Finance article listing four Alzheimer's drug stocks to watch on World Alzheimer's Day. This inclusion highlights the company's relevance in the neurodegenerative disease sector. The stock is currently trading near its 52-week low, with technical indicators showing a rejection at support levels.
Prothena included in Alzheimer's Day stock watchlist. Prothena was featured in a Yahoo Finance article listing four Alzheimer's drug stocks to watch on World Alzheimer's Day. This inclusion highlights the company's relevance in the neurodegenerative disease sector. The stock is currently trading near its 52-week low, with technical indicators showing a rejection at support levels.